Abstract:Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. In recent years, continuous discoveries of new ALS-causing genes have enhanced the understanding of the genotype–phenotype relationship in ALS, aiding in disease progression prediction and providing a more comprehensive basis for genetic diagnosis. Methods A total of 1672 ALS patients who visited the Neurology Department of Peking Union Medical College Hospital between January 2014 and December 2022 and met the revised El Escorial diagnostic criteria were included. Clinical data were collected, whole exome sequencing and dynamic mutation screening of the C9ORF72 gene were performed, and the clinical phenotypes and genotypes of the patients were analyzed. Results The average age of onset for the 1672 ALS patients was 52.6 ± 11.2 years (range 17–85 years), with a median disease duration of 14 months at the time of visit (interquartile range 9–24 months, range 2–204 months). The male to female ratio was 833:839. The patients included 297 (17.8%) with bulbar onset, 198 (11.8%) with flail arm/leg syndrome, 89 (5.3%) with familial ALS, and 52 (3.1%) with concomitant frontotemporal dementia (FTD). Pathogenic variants associated with ALS were detected in 175 patients (10.5% of the cohort), with the most common mutations being SOD1 , FUS , and ANXA11 . Among patients with familial ALS, 56.2% (50/89) had genetic mutations, compared to 7.9% (125/1583) in sporadic ALS cases. From the perspective of phenotype-genotype correlation, (1) In ALS-FTD patients, the most common genetic mutations were ANXA11 and C9ORF72 repeat expansions. Patients with flail arm/leg syndrome more frequently carried mutations in SOD1 , ANXA11 , and hnRNPA1 ; (2) Despite genetic heterogeneity, it was observed that mutations in FUS and NEK1 were more common in males, and patients with FUS mutations had a younger age of onset; mutations in SOD1 and SQSTM1 were more likely to present with lower limb onset. Conclusion This study provides comprehensive data on the genetic characteristics of ALS patients in China through large-scale clinical data and genetic analysis of 1672 cases. Differences in age of onset, onset site, and clinical phenotype among ALS patients with different genotypes can help clinicians better predict disease progression and provide a basis for precise diagnosis and individualized treatment.

Association Between Rare UBQLN2 Variants and Amyotrophic Lateral Sclerosis in Chinese Population

Presence of Rare Variants is Associated with Poorer Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.

Two new cases with the UBQLN2 gene mutation in Han Chinese

No Evidence for Pathogenic Role of UBQLN2 Mutations in Sporadic Amyotrophic Lateral Sclerosis in the Mainland Chinese Population.

Rare CYLD Variants in Chinese Patients with Amyotrophic Lateral Sclerosis

Mutation Spectrum of Chinese Patients with Familial and Sporadic Amyotrophic Lateral Sclerosis

[Rare Variants of HSPB1 Are Probably Associated with Amyotrophic Lateral Sclerosis].

Clinical and genetic characteristics of 1672 cases of amyotrophic lateral sclerosis in China: a single-center retrospective study

Rare, Low-Frequency and Common Coding Variants of ARHGEF28 Gene and Their Association with Sporadic Amyotrophic Lateral Sclerosis.

Genetic Spectrum and Variability in Chinese Patients with Amyotrophic Lateral Sclerosis.

Role of Genetics in Amyotrophic Lateral Sclerosis: a Large Cohort Study in Chinese Mainland Population.

Association Analysis of Four Candidate Genetic Variants with Sporadic Amyotrophic Lateral Sclerosis in a Chinese Population

Rare, Pathogenic Variants in LRP10 Are Associated with Amyotrophic Lateral Sclerosis in Patients from Mainland China.

Analysis of <i>ERBB4</i> Variants in Amyotrophic Lateral Sclerosis Within a Chinese Cohort

Genetic Analysis of and Clinical Characteristics Associated with ANXA11 Variants in a Chinese Cohort with Amyotrophic Lateral Sclerosis

Validation of the pathogenic role of rare DNAJC7 variants in Chinese patients with amyotrophic lateral sclerosis

Genotype-phenotype correlation of SQSTM1 variants in patients with amyotrophic lateral sclerosis

Mutation Screening of ATXN1, ATXN2, and ATXN3 in Amyotrophic Lateral Sclerosis

Mutation Screening of SPTLC1 and SPTLC2 in Amyotrophic Lateral Sclerosis

Burden of rare variants in ALS genes influences survival in familial and sporadic ALS.

Novel and Recurrent Mutations in a Cohort of Chinese Patients with Young-Onset Amyotrophic Lateral Sclerosis